The Effect of Switching Therapy to Pegaptanib in Eyes with the Persistent Cases of Exudative Age-related Macular Degeneration.
Phase of Trial: Phase II
Latest Information Update: 19 May 2016
At a glance
- Drugs Pegaptanib (Primary) ; Ranibizumab
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 06 Dec 2015 New trial record